Literature DB >> 1747867

Establishment of a rhabdoid tumor cell line with a specific chromosomal abnormality, 46,XY,t(11;22)(p15.5;q11.23).

P S Karnes1, T N Tran, M Y Cui, E Bogenmann, H Shimada, K L Ying.   

Abstract

The malignant rhabdoid tumor is a rare, poorly understood tumor which occurs primarily in children. The kidney is a frequent primary site of origin, but the tumor has arisen in other mesodermally derived tissues as well. Controversy exists regarding the embryonic origin of the rhabdoid tumor and recent histopathologic studies suggest that it may be of neuroepithelial origin. Our immunohistochemical and electron micrographic studies support this theory. No consistent chromosome abnormalities have been reported in this tumor and no cell lines are available for study. We have established and characterized the first rhabdoid tumor cell line. It possesses a specific chromosomal abnormality, 46,XY,t(11;22)(p15.5;q11.23). The translocation may provide an important clue to the pathogenesis of the tumor as well as an opportunity for further study of the involved chromosome regions.

Entities:  

Mesh:

Year:  1991        PMID: 1747867     DOI: 10.1016/0165-4608(91)90359-3

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  10 in total

1.  Maternal gametic transmission of translocations or inversions of human chromosome 11p15.5 results in regional DNA hypermethylation and downregulation of CDKN1C expression.

Authors:  Adam C Smith; Masako Suzuki; Reid Thompson; Sanaa Choufani; Michael J Higgins; Idy W Chiu; Jeremy A Squire; John M Greally; Rosanna Weksberg
Journal:  Genomics       Date:  2011-11-03       Impact factor: 5.736

Review 2.  Clinicopathologic and cytogenetic analysis of malignant rhabdoid tumor of the central nervous system.

Authors:  R P Hasserjian; R D Folkerth; R M Scott; D E Schofield
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

3.  Epigenetic modification after inhibition of IGF-1R signaling in human central nervous system atypical teratoid rhabdoid tumor (AT/RT).

Authors:  Kyu-Won Shim; Guifa Xi; Barbara-Mania Farnell; Dong-Seok Kim; Takao Tsurubuchi; Tadanori Tomita; C Shekhar Mayanil
Journal:  Childs Nerv Syst       Date:  2013-04-28       Impact factor: 1.475

4.  Oncolytic efficacy of recombinant vesicular stomatitis virus and myxoma virus in experimental models of rhabdoid tumors.

Authors:  Yushui Wu; Xueqing Lun; Hongyuan Zhou; Limei Wang; Beichen Sun; John C Bell; John W Barrett; Grant McFadden; Jaclyn A Biegel; Donna L Senger; Peter A Forsyth
Journal:  Clin Cancer Res       Date:  2008-02-15       Impact factor: 12.531

5.  Successful treatment for a metastatic supratentorial malignant rhabdoid tumor.

Authors:  E Bouffet; D Frappaz; D Dolbeau; H Sobol; A Jouvet; C Carrie; C Pondarre; M Brunat-Mentigny; T Philip; C Mottolese
Journal:  J Neurooncol       Date:  1993-07       Impact factor: 4.130

6.  The G401 cell line, utilized for studies of chromosomal changes in Wilms' tumor, is derived from a rhabdoid tumor of the kidney.

Authors:  A J Garvin; G G Re; B I Tarnowski; D J Hazen-Martin; D A Sens
Journal:  Am J Pathol       Date:  1993-02       Impact factor: 4.307

7.  A common region of loss of heterozygosity in Wilms' tumor and embryonal rhabdomyosarcoma distal to the D11S988 locus on chromosome 11p15.5.

Authors:  C Besnard-Guérin; I Newsham; R Winqvist; W K Cavenee
Journal:  Hum Genet       Date:  1996-02       Impact factor: 4.132

8.  Multiple genetic loci within 11p15 defined by Beckwith-Wiedemann syndrome rearrangement breakpoints and subchromosomal transferable fragments.

Authors:  J M Hoovers; L M Kalikin; L A Johnson; M Alders; B Redeker; D J Law; J Bliek; M Steenman; M Benedict; J Wiegant; C Lengauer; P Taillon-Miller; D Schlessinger; M C Edwards; S J Elledge; A Ivens; A Westerveld; P Little; M Mannens; A P Feinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-19       Impact factor: 11.205

9.  Establishment and characterization of MRT cell lines from genetically engineered mouse models and the influence of genetic background on their development.

Authors:  Yasumichi Kuwahara; E Lorena Mora-Blanco; Fatima Banine; Arlin B Rogers; Christopher Fletcher; Larry S Sherman; Charles W M Roberts; Bernard E Weissman
Journal:  Int J Cancer       Date:  2012-12-27       Impact factor: 7.396

10.  Characterization of a new human embryonal rhabdomyosarcoma cell line, RMS-GR.

Authors:  J E Fernández; J Prados; C Melquizo; N Arena; F Malavasi; L Alvarez; A Aránega
Journal:  Jpn J Cancer Res       Date:  1998-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.